BlackRock
REGN icon

BlackRock’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.87B Buy
9,276,085
+350,205
+4% +$184M 0.09% 179
2025
Q1
$5.66B Buy
8,925,880
+194,258
+2% +$123M 0.12% 144
2024
Q4
$6.22B Buy
8,731,622
+251,360
+3% +$179M 0.13% 132
2024
Q3
$8.91B Buy
8,480,262
+33,896
+0.4% +$35.6M 0.19% 90
2024
Q2
$8.88B Sell
8,446,366
-122,288
-1% -$129M 0.2% 84
2024
Q1
$8.25B Sell
8,568,654
-61,053
-0.7% -$58.8M 0.19% 92
2023
Q4
$7.58B Sell
8,629,707
-245,602
-3% -$216M 0.19% 91
2023
Q3
$7.3B Sell
8,875,309
-210,673
-2% -$173M 0.21% 80
2023
Q2
$6.53B Sell
9,085,982
-332,318
-4% -$239M 0.18% 98
2023
Q1
$7.74B Buy
9,418,300
+251,483
+3% +$207M 0.23% 75
2022
Q4
$6.61B Sell
9,166,817
-320,426
-3% -$231M 0.21% 88
2022
Q3
$6.54B Sell
9,487,243
-847
-0% -$583K 0.22% 79
2022
Q2
$5.61B Sell
9,488,090
-96,861
-1% -$57.3M 0.18% 94
2022
Q1
$6.69B Sell
9,584,951
-25,920
-0.3% -$18.1M 0.18% 94
2021
Q4
$6.07B Buy
9,610,871
+244,009
+3% +$154M 0.15% 106
2021
Q3
$5.67B Buy
9,366,862
+333,312
+4% +$202M 0.16% 106
2021
Q2
$5.05B Sell
9,033,550
-615,998
-6% -$344M 0.14% 121
2021
Q1
$4.57B Sell
9,649,548
-126,638
-1% -$59.9M 0.13% 127
2020
Q4
$4.72B Sell
9,776,186
-15,866
-0.2% -$7.67M 0.15% 114
2020
Q3
$5.48B Buy
9,792,052
+2,479
+0% +$1.39M 0.2% 85
2020
Q2
$6.11B Buy
9,789,573
+3,191,724
+48% +$1.99B 0.24% 73
2020
Q1
$3.22B Buy
6,597,849
+459,001
+7% +$224M 0.16% 120
2019
Q4
$2.31B Sell
6,138,848
-120,638
-2% -$45.3M 0.09% 211
2019
Q3
$1.74B Buy
6,259,486
+213,834
+4% +$59.3M 0.07% 259
2019
Q2
$1.89B Buy
6,045,652
+2,744
+0% +$859K 0.08% 238
2019
Q1
$2.48B Buy
6,042,908
+113,683
+2% +$46.7M 0.11% 178
2018
Q4
$2.21B Buy
5,929,225
+67,241
+1% +$25.1M 0.11% 175
2018
Q3
$2.37B Sell
5,861,984
-128,855
-2% -$52.1M 0.1% 187
2018
Q2
$2.07B Sell
5,990,839
-11,286
-0.2% -$3.89M 0.1% 204
2018
Q1
$2.07B Sell
6,002,125
-9,630
-0.2% -$3.32M 0.1% 201
2017
Q4
$2.26B Sell
6,011,755
-117,640
-2% -$44.2M 0.11% 185
2017
Q3
$2.74B Sell
6,129,395
-58,872
-1% -$26.3M 0.14% 142
2017
Q2
$3.04B Buy
6,188,267
+41,406
+0.7% +$20.3M 0.16% 120
2017
Q1
$2.38B Buy
6,146,861
+5,967,733
+3,332% +$2.31B 0.13% 154
2016
Q4
$65.8M Sell
179,128
-26,565
-13% -$9.75M 0.09% 249
2016
Q3
$82.7M Buy
205,693
+19,015
+10% +$7.64M 0.12% 189
2016
Q2
$65.2M Buy
186,678
+38,173
+26% +$13.3M 0.1% 226
2016
Q1
$53.5M Sell
148,505
-47,863
-24% -$17.3M 0.09% 259
2015
Q4
$107M Sell
196,368
-7,543
-4% -$4.09M 0.16% 149
2015
Q3
$94.8M Sell
203,911
-5,553
-3% -$2.58M 0.15% 165
2015
Q2
$107M Sell
209,464
-38,020
-15% -$19.4M 0.16% 144
2015
Q1
$112M Sell
247,484
-3,580
-1% -$1.62M 0.15% 151
2014
Q4
$103M Sell
251,064
-254
-0.1% -$104K 0.15% 153
2014
Q3
$90.6M Sell
251,318
-24,673
-9% -$8.9M 0.13% 165
2014
Q2
$78M Buy
275,991
+21,273
+8% +$6.01M 0.12% 195
2014
Q1
$76.5M Buy
254,718
+10,343
+4% +$3.11M 0.12% 187
2013
Q4
$67.3M Buy
244,375
+61,837
+34% +$17M 0.11% 209
2013
Q3
$57.1M Buy
182,538
+20,697
+13% +$6.48M 0.11% 207
2013
Q2
$36.4M Buy
+161,841
New +$36.4M 0.07% 280